Hahn, K.A.; Oglivie, G.; Rusk, T.; Devauchelle, P.; Leblanc, A.; Legendre, A.; Powers, B.; Leventhal, P.S.; Kinet, J.-P.; Palmerini, F.; Dubreuil, P.; Moussy, A.; Hermine, O. (2008). "Masitinib is Safe and Effective for the Treatment of Canine Mast Cell Tumors". Journal of Veterinary Internal Medicine. 22 (6): 1301–1309. doi:10.1111/j.1939-1676.2008.0190.x. ISSN0891-6640.
Folch, J; Petrov, D; Ettcheto, M; Pedrós, I; Abad, S; Beas-Zarate, C; Lazarowski, A; Marin, M; Olloquequi, J; Auladell, C; Camins, A (June 2015). "Masitinib for the treatment of mild to moderate Alzheimer's disease". Expert review of neurotherapeutics. 15 (6): 587–96. doi:10.1586/14737175.2015.1045419. PMID25961655.
Gil da Costa, RM (July 2015). "C-kit as a prognostic and therapeutic marker in canine cutaneous mast cell tumours: From laboratory to clinic". Veterinary journal (London, England : 1997). 205 (1): 5–10. doi:10.1016/j.tvjl.2015.05.002. PMID26021891.
«نسخه آرشیو شده». بایگانیشده از اصلی در ۱۷ اكتبر ۲۰۱۷. دریافتشده در ۲۴ اوت ۲۰۱۹. تاریخ وارد شده در |archive-date= را بررسی کنید (کمک)
nih.gov
pubmed.ncbi.nlm.nih.gov
Folch, J; Petrov, D; Ettcheto, M; Pedrós, I; Abad, S; Beas-Zarate, C; Lazarowski, A; Marin, M; Olloquequi, J; Auladell, C; Camins, A (June 2015). "Masitinib for the treatment of mild to moderate Alzheimer's disease". Expert review of neurotherapeutics. 15 (6): 587–96. doi:10.1586/14737175.2015.1045419. PMID25961655.
Gil da Costa, RM (July 2015). "C-kit as a prognostic and therapeutic marker in canine cutaneous mast cell tumours: From laboratory to clinic". Veterinary journal (London, England : 1997). 205 (1): 5–10. doi:10.1016/j.tvjl.2015.05.002. PMID26021891.
